Sang Uk Kim

Title: Innovations of Sang Uk Kim in Target-Specific Non-Antibody Proteins

Introduction

Sang Uk Kim is an accomplished inventor based in Gyeongbuk, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of target-specific non-antibody proteins. His innovative work has the potential to impact cancer therapeutics significantly.

Latest Patents

Sang Uk Kim holds a patent for a "Target-specific non-antibody protein and method for preparing the same." This invention relates to a method for preparing a target-specific non-antibody protein. The method involves selecting non-antibody proteins that have structural complementarity with the target site of a target protein from a non-antibody protein library. It includes calculating the binding energy of the selected non-antibody protein and the target protein, selecting a non-antibody protein with favorable binding energy, and substituting specific amino acid residues to enhance binding affinity. Notably, this invention includes a target-specific non-antibody that binds specifically with the EGFR (Epidermal Growth Factor Receptor) domain 2, which is crucial for cancer treatment.

Career Highlights

Sang Uk Kim is associated with the Postech Academy-Industry Foundation, where he continues to advance his research and innovations. His work is characterized by a strong focus on practical applications in the medical field, particularly in cancer therapy.

Collaborations

He collaborates with notable colleagues, including Yoon Sup Choi and Jun Ho Chung, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Sang Uk Kim's innovative work in developing target-specific non-antibody proteins showcases his commitment to advancing biotechnology and improving cancer treatment options. His contributions are paving the way for future advancements in therapeutic applications.